Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas.

Tiemersma EW, Bunschoten A, Kok FJ, Glatt H, de Boer SY, Kampman E.

Int J Cancer. 2004 Jan 1;108(1):97-103.

2.

Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.

Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):99-107.

3.

Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.

Moslehi R, Chatterjee N, Church TR, Chen J, Yeager M, Weissfeld J, Hein DW, Hayes RB.

Pharmacogenomics. 2006 Sep;7(6):819-29.

PMID:
16981843
4.

Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study.

Tiemersma EW, Kampman E, Bueno de Mesquita HB, Bunschoten A, van Schothorst EM, Kok FJ, Kromhout D.

Cancer Causes Control. 2002 May;13(4):383-93.

PMID:
12074508
5.

Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.

Okkels H, Sigsgaard T, Wolf H, Autrup H.

Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):225-31.

6.

Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk.

Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P.

Am J Epidemiol. 2010 Nov 1;172(9):1000-14. doi: 10.1093/aje/kwq245. Epub 2010 Oct 11.

7.

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.

Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S.

Int J Cancer. 2004 Jul 1;110(4):598-604.

8.

Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.

Potter JD, Bigler J, Fosdick L, Bostick RM, Kampman E, Chen C, Louis TA, Grambsch P.

Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):69-75.

9.

Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population.

Ozawa S, Katoh T, Inatomi H, Imai H, Kuroda Y, Ichiba M, Ohno Y.

Int J Cancer. 2002 Dec 1;102(4):418-21. Erratum in: Int J Cancer. 2003 May 10;104(6):798.

10.
11.

CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.

Hamachi T, Tajima O, Uezono K, Tabata S, Abe H, Ohnaka K, Kono S.

World J Gastroenterol. 2013 Jul 7;19(25):4023-30. doi: 10.3748/wjg.v19.i25.4023.

12.

Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas.

Ishibe N, Sinha R, Hein DW, Kulldorff M, Strickland P, Fretland AJ, Chow WH, Kadlubar FF, Lang NP, Rothman N.

Pharmacogenetics. 2002 Mar;12(2):145-50.

PMID:
11875368
13.

N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.

da Silva TD, Felipe AV, de Lima JM, Oshima CT, Forones NM.

World J Gastroenterol. 2011 Feb 14;17(6):760-5. doi: 10.3748/wjg.v17.i6.760.

14.

The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.

Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL, Bell DA.

Cancer Res. 1998 Aug 15;58(16):3603-10.

15.

Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Osada Y, Katoh T.

J Cancer Res Clin Oncol. 2004 Feb;130(2):99-106. Epub 2003 Nov 27.

PMID:
14648207
16.

Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population.

Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, La Greca A, D'Ugo D, La Torre G, van Duijn CM, Ricciardi G.

BMC Cancer. 2007 Nov 8;7:206.

17.

Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas.

Probst-Hensch NM, Haile RW, Li DS, Sakamoto GT, Louie AD, Lin BK, Frankl HD, Lee ER, Lin HJ.

Carcinogenesis. 1996 Oct;17(10):2125-9.

PMID:
8895478
18.

Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population.

Tiemersma EW, Voskuil DW, Bunschoten A, Hogendoorn EA, Witteman BJ, Nagengast FM, Glatt H, Kok FJ, Kampman E.

Cancer Causes Control. 2004 Apr;15(3):225-36.

PMID:
15090717
19.

Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.

Kiss I, Németh A, Bogner B, Pajkos G, Orsós Z, Sándor J, Csejtey A, Faluhelyi Z, Rodler I, Ember I.

Anticancer Res. 2004 Nov-Dec;24(6):3965-70.

Supplemental Content

Support Center